Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | CASP3 | P42574 | 4/20 | 0.49 |
| ▸ | MDM4 | O15151 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.45 |
| ▸ | TLR2 | O60603 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30554761 | 1.00 | KMT2A (0.51) | KMT2ACASP3MDM4TP53FDFT1 | |
| SCHEMBL14787175 | 0.92 | MDM4 (0.48) | KMT2ACASP3MDM4TP53FDFT1 | |
| SCHEMBL31658231 | 0.90 | TLR2 (0.53) | KMT2ACASP3MDM4TP53FDFT1 | |
| SCHEMBL31315496 | 0.90 | KMT2A (0.58) | KMT2ACASP3MDM4TP53TLR2 | |
| SCHEMBL17446831 | 0.89 | MDM4 (0.46) | KMT2ACASP3MDM4TP53TLR2 | |
| SCHEMBL18257538 | 0.88 | KMT2A (0.46) | KMT2ACASP3MDM4TP53FDFT1 | |
| SCHEMBL8140875 | 0.88 | CASP3 (0.51) | KMT2ACASP3MDM4TP53TLR2 | |
| SCHEMBL14789147 | 0.88 | KMT2A (0.50) | KMT2ACASP3MDM4TP53TLR2 | |
| SCHEMBL1855026 | 0.88 | KMT2A (0.50) | KMT2ACASP3MDM4TP53 | |
| SCHEMBL31041123 | 0.88 | KMT2A (0.50) | KMT2ACASP3MDM4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9127039-B2 | Sulfur-containing amino acid derivative | AJINOMOTO CO., INC. (JP) | 2015-09-08 | — | — | US | disclosed |
| US-9127039-B2 | Sulfur-containing amino acid derivative | AJINOMOTO CO., INC. (JP) | 2015-09-08 | — | — | US | disclosed |
| US-20130071863-A1 | Sulfur-Containing Amino Acid Derivative | AJINOMOTO CO., INC. (JP) | 2013-03-21 | — | — | US | disclosed |
| US-20130071863-A1 | Sulfur-Containing Amino Acid Derivative | AJINOMOTO CO., INC. (JP) | 2013-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130071863-A1 | Sulfur-Containing Amino Acid Derivative | SLC7A5, CTH, CBS | KMT2A 2230/4885CASP3 4761/4885MDM4 1996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.